Archive Newsletter
-
10.28.26 -- Accelerating Advanced Therapies: From Development To Manufacturing
10/28/2026
10/28/26 Outsourced Pharma Newsletter
-
10.28.26 -- The Manufacturing Reality Behind Advanced Therapy Commercial Scale
10/28/2026
10/28/26 Cell & Gene Newsletter
-
10.28.26 -- Building More Scalable MSC Processes
10/28/2026
10/28/26 Cell & Gene Newsletter
-
10.28.26 -- Inside The Pursuit Of A Functional Cure For Type 1 Diabetes
10/28/2026
10/28/26 Cell & Gene Newsletter
-
10.27.26 -- Reduce Bioprocessing Supply Risk With Manufacturing Closer To You
10/27/2026
10/27/26 Cell & Gene Newsletter
-
10.27.26 -- Advancing Cell Therapy Toward A Functional Cure For T1D With Forthcoming BetaNova's Jonathan Rigby And Will Rust, Ph.D.
10/27/2026
10/27/26 Cell & Gene Newsletter
-
10.27.26 -- The 5 Shifts That Could Remake Lyophilization By 2040
10/27/2026
10/27/26 Cell & Gene Newsletter
-
10.26.26 -- OPCU: Fill/Finish Strategies For Protecting Advanced Therapy Products
10/26/2026
10/26/26 Cell & Gene Newsletter
-
10.26.26 -- Breaking Down Development Silos In In Vivo CGT Manufacturing
10/26/2026
10/26/26 Cell & Gene Newsletter
-
10.23.26 -- Digitalization And Traceability Reshaping Cleanroom Compliance
10/23/2026
10/23/26 Cell & Gene Newsletter